Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2020-12-02 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: STRASBOURG (67000), Bas-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE DE L'OURS : revenue, balance sheet and financial ratios
SELAS PHARMACIE DE L'OURS is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in STRASBOURG (67000),
this company of category PME
shows in 2023 a net income positive of 25 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DE L'OURS (SIREN 892032202)
Indicator
2023
2022
2021
Revenue
N/C
N/C
N/C
Net income
24 583 €
69 229 €
-30 343 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2023, SELAS PHARMACIE DE L'OURS generates positive net income of 25 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
24 583 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 2152%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 4%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
2152.047%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
3.941%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DE L'OURS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
Debt ratio
-8011.124
3103.122
2152.047
Financial autonomy
-1.094
2.674
3.941
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
2152.052023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Watch+50 pts over 3 years
In 2023, the debt ratio of SELAS PHARMACIE DE L'OURS (2152.05) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
3.94%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of SELAS PHARMACIE DE L'OURS (3.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 157.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
157.415
Liquidity indicators evolution SELAS PHARMACIE DE L'OURS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
2023
Liquidity ratio
120.006
106.614
157.415
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
157.412023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Average+13 pts over 3 years
In 2023, the liquidity ratio of SELAS PHARMACIE DE L'OURS (157.41) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELAS PHARMACIE DE L'OURS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELAS PHARMACIE DE L'OURS is estimated at
290 066 €
(range 176 403€ - 407 768€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
176k€290k€407k€
290 066 €Range: 176 403€ - 407 768€
NAF 5 année 2023
Valuation method used
Net Income Multiple
24 583 €
×
11.8x
=290 067 €
Range: 176 403€ - 407 768€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DE L'OURS with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DE L'OURS
What is the revenue of SELAS PHARMACIE DE L'OURS ?
The revenue of SELAS PHARMACIE DE L'OURS is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE DE L'OURS profitable?
Yes, SELAS PHARMACIE DE L'OURS generated a net profit of 25 k€ in 2023.
Where is the headquarters of SELAS PHARMACIE DE L'OURS ?
The headquarters of SELAS PHARMACIE DE L'OURS is located in STRASBOURG (67000), in the department Bas-Rhin.
Where to find the tax return of SELAS PHARMACIE DE L'OURS ?
The tax return of SELAS PHARMACIE DE L'OURS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DE L'OURS operate?
SELAS PHARMACIE DE L'OURS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart